Satellos Bioscience Inc.

MSLE chart

Satellos Bioscience Inc. news

• Satellos Bioscience at Guggenheim: FDA path sharpens for DMD drug By Investing.com

  Investing.com Australia · Nov 9, 10:42 AM EST

• Satellos Bioscience Inc. expected to post a loss of 56 cents a share - Earnings Preview

  TradingView · Nov 9, 8:41 AM EST

• Insider Stock Buyers At Satellos Bioscience Recouped Some Losses This Week

  Simply Wall St · Nov 9, 5:33 AM EST

• Satellos Bioscience Inc. (MSCL.TO) Seasonal returns chart

  Yahoo Finance UK · Nov 7, 1:12 PM EST

• Satellos Bioscience Sets Duchenne Trial Endpoint After FDA Talks, Eyes 2027 Results

  marketbeat.com · Nov 6, 9:14 PM EST

• Satellos Bioscience Inc. (MSLE) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Nov 6, 7:31 PM EST

• Stocks in play: Satellos Bioscience Inc.

  The Globe and Mail · Nov 6, 2:09 PM EST

• Satellos Changes Primary Efficacy Endpoint in BASECAMP Phase 2 Pediatric Trial to MRI-Measured Fat Fraction Following FDA Feedback

  Yahoo Finance · Nov 6, 7:00 AM EST

• A November 6 Satellos (MSLE) call will cover its DMD study in boys ages 7, 8 or 9.

  Stock Titan · Nov 5, 4:32 PM EST

• Satellos to Host Investor Call to Provide an Update on Clinical and Regulatory Strategy for the BASECAMP Phase 2 Pediatric Study

  Yahoo Finance · Nov 5, 4:32 PM EST

• A Friday call will discuss a Duchenne muscular dystrophy study for boys ages 7 to 9

  Stock Titan · Nov 5, 4:32 PM EST

• Satellos Establishes Scientific Advisory Board to Explore the Biology of Regeneration in Aging and Neuroscience

  Yahoo Finance · Oct 27, 7:00 AM EDT

Satellos Bioscience Inc. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KFORM 6-K2026-11-06
• 6-KFORM 6-K2026-11-05
• 6-KFORM 6-K2026-10-27
• 6-KFORM 6-K2026-10-21
• 6-KFORM 6-K2026-10-05
• 6-KFORM 6-K2026-09-30
• 6-KFORM 6-K2026-09-24
• 6-KFORM 6-K2026-09-15
• 6-KFORM 6-K2026-09-09
• 6-KFORM 6-K2026-09-01
• 6-KFORM 6-K2026-08-14
• 6-KFORM 6-K2026-08-13

About Satellos Bioscience Inc.

Ticker

MSLE (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Markham

Incorporated in

Canada (Federal Level)

Fiscal year end

December 31

SEC CIK

1421642

Former names

ICO THERAPEUTICS INC

Frequently asked questions